Phase-II trial of rituximab in patients with relapsed CD20-positive Hodgkin's lymphoma: An update from the German Hodgkin's Lymphoma Study Group (GHSG).

被引：0
|
作者：
Schulz, H
Rehwald, U
Reiser, M
Ruediger, T
Morschhauser, F
Diehl, V
Engert, A
机构：
[1] Univ Cologne, Dept Internal Med 1, D-5000 Cologne 41, Germany
[2] Univ Wurzburg, Dept Pathol, D-8700 Wurzburg, Germany
[3] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3066
引用
收藏
页码：775A / 775A
页数：1
相关论文
共 50 条
  • [1] Rituximab in relapsed lymphocyte-predominant Hodgkin's lymphoma:: Long-term results of a phase-II trial by the German Hodgkin lymphoma Study Group (GHSG)
    Schulz, H.
    Rehwald, U.
    Morschhauser, F.
    Elter, T.
    Driessen, C.
    Ruediger, T.
    Borchmann, P.
    Schnell, R.
    Diehl, V.
    Engert, A.
    Reiser, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 57 - 57
  • [2] Rituximab in relapsed lymphocyte predominant Hodgkin's disease (LPHD). Long-term results of a phase-II study from the German Hodgkin Lymphoma Study Group (GHSG).
    Schulz, H
    Trelle, S
    Reiser, M
    Sieber, M
    Diehl, V
    Engert, A
    BLOOD, 2005, 106 (11) : 433A - 433A
  • [3] A prognostic score for patients with relapsed Hodgkin lymphoma registered in the database of the German Hodgkin's lymphoma study group (GHSG).
    Josting, A
    Franklin, J
    May, M
    Rueffer, U
    Sieber, M
    Paulus, U
    Wolf, J
    Diehl, V
    Engert, A
    BLOOD, 2000, 96 (11) : 134A - 134A
  • [4] Hodgkin's lymphoma in elderly patients: A comprehensive analysis of the German Hodgkin lymphoma study group (GHSG).
    Engert, A
    Ballova, V
    Haverkamp, H
    Pfistner, B
    Diehl, V
    BLOOD, 2004, 104 (11) : 368A - 368A
  • [5] Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma:: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)
    Schulz, Holger
    Rehwald, Ute
    Morschhauser, Franck
    Elter, Thomas
    Driessen, Christoph
    Ruediger, Thomas
    Borchmann, Peter
    Schnell, Roland
    Diehl, Volker
    Engert, Andreas
    Reiser, Marcel
    BLOOD, 2008, 111 (01) : 109 - 111
  • [6] Relapsed Hodgkin Lymphoma in Elderly Patients: A Comprehensive Analysis From the German Hodgkin Study Group (GHSG)
    Boell, Boris
    Goergen, Helen
    Arndt, Nils
    Pluetschow, Annette
    Fuchs, Michael
    Diehl, Volker
    Engert, Andreas
    Naumann, Ralph
    Borchmann, Peter
    BLOOD, 2011, 118 (21) : 44 - 45
  • [7] A new BACOPP schedule is feasible and effective in elderly Hodgkin's lymphoma patients -: Interim results of a multicenter phase-II trial of the German Hodgkin Study Group (GHSG)
    Nogová, L
    Sieniawski, M
    Nisters-Backes, H
    Jennissen, V
    Klimm, B
    Wielckens, K
    Diehl, V
    Josting, A
    ANNALS OF ONCOLOGY, 2005, 16 : 195 - 195
  • [8] New BACOPP schedule is feasible and effective in elderly Hodgkin's lymphoma patients - Interim results of a multicenter phase-II trial of the German Hodgkin Study Group (GHSG).
    Nogova, L
    Sieniawski, M
    Nisters-Backes, H
    Jennissen, V
    Diehl, V
    Engert, A
    Josting, A
    BLOOD, 2005, 106 (11) : 264B - 264B
  • [9] Salvage radiotherapy in patients with relapsed and refractory Hodgkin lymphoma - A retrospective analyis from the German Hodgkin Lymphoma Study Group (GHSG).
    Josting, A
    Sieber, M
    Franklin, J
    Glossmann, JP
    May, M
    Diehl, V
    Engert, A
    BLOOD, 2002, 100 (11) : 774A - 774A
  • [10] Fertility in male patients with Hodgkin's disease - Results from the German Hodgkin Lymphoma Study Group (GHSG).
    Sieniawski, M
    Josting, A
    Breuer, K
    Diehl, V
    Engert, A
    BLOOD, 2004, 104 (11) : 370A - 370A
12345